يعرض 1 - 20 نتائج من 637 نتيجة بحث عن '"González‐Martín, Antonio"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Monk , B J , Romero , I , Graybill , W , Churruca , C , O'Malley , D M , Knudsen , A Ø , Yap , O W S , Baurain , J F , Rose , P G , Denys , H , Ghamande , S , Pisano , C , Fabbro , M , Braicu , E I , Calvert , P M , Amit , A , Prendergast , E , Taylor , A , Kheibarshekan , L , Zhang , Z Y , Zajic , S , Jewell , R C , ....

    وصف الملف: application/pdf

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المساهمون: A. Oaknin, J. Lee, V. Makker, D. Oh, S. Banerjee, A. González-Martín, K.H. Jung, I. Ługowska, L. Manso, A. Manzano, B. Melichar, S. Siena, D. Stroyakovskiy, A. Fielding, S. Puvvada, A. Smith, F. Meric-Bernstam

    Relation: info:eu-repo/semantics/altIdentifier/pmid/39261417; info:eu-repo/semantics/altIdentifier/wos/WOS:001310010900001; volume:41; issue:11; firstpage:4125; lastpage:4139; numberofpages:15; journal:ADVANCES IN THERAPY; https://hdl.handle.net/2434/1099129

  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المساهمون: Institut Català de la Salut, Meric-Bernstam F Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX. Makker V Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY. Department of Medicine, Weill Cornell Medical College, New York, NY. Oaknin A Gynaecologic Cancer Programme, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Oh DY Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea. Banerjee S Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom. Gonzalez-Martín A Medical Oncology Department and Programme in Solid TumoursCIMA, Cancer Center Clínica Universidad de Navarra, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Oncology;42(1); https://doi.org/10.1200/JCO.23.02005; Meric-Bernstam F, Makker V, Oaknin A, Oh DY, Banerjee S, González-Martín A, et al. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial. J Clin Oncol. 2024 Jan;42(1):47–58.; https://hdl.handle.net/11351/10905; 001130404400013

  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    المساهمون: Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Centre Léon Bérard Lyon, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 2666-3791 ; Cell Reports Medicine ; https://cnrs.hal.science/hal-04400735 ; Cell Reports Medicine, 2023, 4, ⟨10.1016/j.xcrm.2023.101344⟩.

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

  18. 18
    Academic Journal
  19. 19
  20. 20
    Academic Journal

    المساهمون: Institut Català de la Salut, Santin AD Yale School of Medicine, New Haven, CT, USA. Vergote I University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. González-Martín A Clinica Universidad de Navarra, Madrid, Spain. Moore K University of Oklahoma Health Sciences Center, Oklahoma, OK, USA. Oaknin A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Romero I Instituto Valenciano de Oncología, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: International Journal of Gynecological Cancer;33(4); http://dx.doi.org/10.1136/ijgc-2022-003927; Santin AD, Vergote I, González-Martín A, Moore K, Oaknin A, Romero I, et al. Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study. Int J Gynecol Cancer. 2023 Apr;33(4):562–70.; https://hdl.handle.net/11351/9375; 000904327300001